UCB


UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases in immunology or neurology. With more than 7 500 people in approximately 40 countries, UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news